The association of nocturnal serum melatonin levels with major depression in patients with acute multiple sclerosis.
The association of nocturnal serum melatonin levels was investigated in acute multiple sclerosis (MS) patients with major depression (MD). The sample comprised 13 patients with MD and 12 with no psychiatric disorders admitted to our clinic due to acute MS attacks. Psychiatric evaluation was performed with the Structured Clinical Interview for DSM-IV (SCD-I). The level of depressive symptoms was assessed with the Beck Depression Scale (BDS). Blood samples were taken from the patients to determine melatonin level at 03.30 h and 10.00 h before steroid treatment started. Melatonin levels were determined using the ELISA test. Nocturnal serum melatonin levels (21.2+/-17.1 pg/ml) of the patients with MD were significantly lower than those (51.5+/-18.3 pg/ml) of the patients without MD. A significant negative correlation was found between BDS scores and nocturnal serum melatonin levels. These findings suggest that a melatonin deficiency may be among the factors involved in the occurrence of depression in MS patients.
Department of Neurology, Meram Faculty of Medicine, Selçuk University, Konya, Turkey.
Zehra
Z
Akpinar
Serhat
S
Tokgöz
Hakki
H
Gökbel
Nilsel
N
Okudan
Faruk
F
Uğuz
Gülsüm
G
Yilmaz
D000208:Acute Disease; D000328:Adult; D002940:Circadian Rhythm / Q000502:physiology*; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000097:blood* / Q000453:epidemiology; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008550:Melatonin / Q000097:blood* / Q000378:metabolism; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood / Q000453:epidemiology*
D008550:Melatonin